Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Corcept Therapeutics
CORT
$12.4B
| $3.95M | ﹤0.01% |
234,678
-291,717
| -55% | -$4.1M |
|
3252
CALL
Hewlett Packard
HPE
$77.7B
| $3.95M | ﹤0.01% |
405,500
+140,300
| +53% | +$1.38M |
|
|
3253
PUT
Hewlett Packard
HPE
$77.7B
| $3.95M | ﹤0.01% |
405,600
+26,000
| +7% | +$255K |
|
|
SAGE
3254
CALL
DELISTED
Sage Therapeutics
SAGE
| $3.95M | ﹤0.01% |
94,900
+6,300
| +7% | +$229K |
|
3255
PUT
Galicia Financial Group
GGAL
$6.97B
| $3.94M | ﹤0.01% |
406,600
+22,700
| +6% | +$194K |
|
3256
PUT
LPL Financial
LPLA
$29.2B
| $3.94M | ﹤0.01% |
50,200
+32,200
| +179% | +$2.15M |
|
|
MODV
3257
DELISTED
ModivCare
MODV
| $3.92M | ﹤0.01% |
49,739
+36,450
| +274% | +$2.47M |
|
3258
Bank of Hawaii
BOH
$3.17B
| $3.92M | ﹤0.01% |
63,901
-44,142
| -41% | -$2.73M |
|
3259
WesBanco
WSBC
$4.09B
| $3.92M | ﹤0.01% |
193,010
+171,114
| +781% | +$3.74M |
|
3260
PUT
Editas Medicine
EDIT
$433M
| $3.92M | ﹤0.01% |
132,500
+62,400
| +89% | +$1.63M |
|
3261
Bank of Montreal
BMO
$130B
| $3.92M | ﹤0.01% |
73,717
-725,946
| -91% | -$37M |
|
3262
PUT
HEICO Corp
HEI
$52.4B
| $3.92M | ﹤0.01% |
39,300
+19,100
| +95% | +$1.76M |
|
3263
Steel Dynamics
STLD
$36.7B
| $3.92M | ﹤0.01% |
150,094
-389,814
| -72% | -$9.75M |
|
3264
CALL
BILL Holdings
BILL
$4.96B
| $3.92M | ﹤0.01% |
43,400
+4,000
| +10% | +$258K |
|
3265
CALL
Protolabs
PRLB
$2.2B
| $3.91M | ﹤0.01% |
34,800
+15,800
| +83% | +$1.62M |
|
|
ACB
3266
CALL
Aurora Cannabis
ACB
$233M
| $3.91M | ﹤0.01% |
31,480
+22,302
| +243% | +$2.54M |
|
3267
CALL
Transocean
RIG
$6.43B
| $3.91M | ﹤0.01% |
2,134,400
+681,600
| +47% | +$1.06M |
|
|
NXGN
3268
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.9M | ﹤0.01% |
355,657
+117,928
| +50% | +$1.22M |
|
3269
Invesco S&P SmallCap Low Volatility ETF
XSLV
$250M
| $3.9M | ﹤0.01% |
115,286
+100,387
| +674% | +$3.33M |
|
|
SCHR
3270
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $3.9M | ﹤0.01% |
+132,790
| New | +$3.89M |
|
3271
CALL
Iridium Communications
IRDM
$5.32B
| $3.9M | ﹤0.01% |
153,300
-18,900
| -11% | -$443K |
|
3272
Ormat Technologies
ORA
$7.06B
| $3.89M | ﹤0.01% |
61,332
+28,778
| +88% | +$1.88M |
|
3273
PUT
Allegiant Air
ALGT
$2.34B
| $3.89M | ﹤0.01% |
35,600
+7,800
| +28% | +$713K |
|
|
BAND
3274
CALL
Bandwidth Inc
BAND
$1.74B
| $3.89M | ﹤0.01% |
30,600
+22,800
| +292% | +$2.3M |
|
3275
CALL
LKQ Corp
LKQ
$6.43B
| $3.88M | ﹤0.01% |
148,300
+112,000
| +309% | +$2.76M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.